United States Sorafenib Market Report 2017

December 2017 | 114 pages | ID: U651388FF40EN
QYResearch

Abstracts

In this report, the United States Sorafenib market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Sorafenib in these regions, from 2012 to 2022 (forecast).

United States Sorafenib market competition by top manufacturers/players, with Sorafenib sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Allergan
• Alnylam Pharmaceuticals
• Acceleron Pharma
• Biocon
• Bionomics
• CASI Pharmaceuticals
• Celgene Corporation
• Enzon Pharmaceuticals
• Five Prime Therapeutics
• Fujifilm Kyowa Kirin Biologics
• Genentech
• Genexine
• Hetero Drugs
• ImClone Systems
• Intas Pharmaceuticals
• Levolta Pharmaceuticals
• Mabtech

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Capsule
• Tablet

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Sorafenib Market Report 2017

1 SORAFENIB OVERVIEW

1.1 Product Overview and Scope of Sorafenib
1.2 Classification of Sorafenib by Product Category
  1.2.1 United States Sorafenib Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Sorafenib Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Capsule
  1.2.4 Tablet
1.3 United States Sorafenib Market by Application/End Users
  1.3.1 United States Sorafenib Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
1.4 United States Sorafenib Market by Region
  1.4.1 United States Sorafenib Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Sorafenib Status and Prospect (2012-2022)
  1.4.3 Southwest Sorafenib Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Sorafenib Status and Prospect (2012-2022)
  1.4.5 New England Sorafenib Status and Prospect (2012-2022)
  1.4.6 The South Sorafenib Status and Prospect (2012-2022)
  1.4.7 The Midwest Sorafenib Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Sorafenib (2012-2022)
  1.5.1 United States Sorafenib Sales and Growth Rate (2012-2022)
  1.5.2 United States Sorafenib Revenue and Growth Rate (2012-2022)

2 UNITED STATES SORAFENIB MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Sorafenib Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Sorafenib Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Sorafenib Average Price by Players/Suppliers (2012-2017)
2.4 United States Sorafenib Market Competitive Situation and Trends
  2.4.1 United States Sorafenib Market Concentration Rate
  2.4.2 United States Sorafenib Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Sorafenib Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES SORAFENIB SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Sorafenib Sales and Market Share by Region (2012-2017)
3.2 United States Sorafenib Revenue and Market Share by Region (2012-2017)
3.3 United States Sorafenib Price by Region (2012-2017)

4 UNITED STATES SORAFENIB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Sorafenib Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Sorafenib Revenue and Market Share by Type (2012-2017)
4.3 United States Sorafenib Price by Type (2012-2017)
4.4 United States Sorafenib Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SORAFENIB SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Sorafenib Sales and Market Share by Application (2012-2017)
5.2 United States Sorafenib Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SORAFENIB PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Sorafenib Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Allergan
  6.2.2 Sorafenib Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Allergan Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Alnylam Pharmaceuticals
  6.3.2 Sorafenib Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Alnylam Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Acceleron Pharma
  6.4.2 Sorafenib Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Acceleron Pharma Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Biocon
  6.5.2 Sorafenib Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biocon Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bionomics
  6.6.2 Sorafenib Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bionomics Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 CASI Pharmaceuticals
  6.7.2 Sorafenib Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 CASI Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Celgene Corporation
  6.8.2 Sorafenib Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Celgene Corporation Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Enzon Pharmaceuticals
  6.9.2 Sorafenib Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Enzon Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Five Prime Therapeutics
  6.10.2 Sorafenib Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Five Prime Therapeutics Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Fujifilm Kyowa Kirin Biologics
6.12 Genentech
6.13 Genexine
6.14 Hetero Drugs
6.15 ImClone Systems
6.16 Intas Pharmaceuticals
6.17 Levolta Pharmaceuticals
6.18 Mabtech

7 SORAFENIB MANUFACTURING COST ANALYSIS

7.1 Sorafenib Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Sorafenib

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Sorafenib Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Sorafenib Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SORAFENIB MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Sorafenib Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Sorafenib Sales Volume Forecast by Type (2017-2022)
11.3 United States Sorafenib Sales Volume Forecast by Application (2017-2022)
11.4 United States Sorafenib Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Sorafenib
Figure United States Sorafenib Market Size (K Pcs) by Type (2012-2022)
Figure United States Sorafenib Sales Volume Market Share by Type (Product Category) in 2016
Figure Capsule Product Picture
Figure Tablet Product Picture
Figure United States Sorafenib Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Sorafenib by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure United States Sorafenib Market Size (Million USD) by Region (2012-2022)
Figure The West Sorafenib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Sorafenib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Sorafenib Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Sorafenib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Sorafenib Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Sorafenib Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Sorafenib Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Sorafenib Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Sorafenib Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Sorafenib Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Sorafenib Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Sorafenib Sales Share by Players/Suppliers
Figure 2017 United States Sorafenib Sales Share by Players/Suppliers
Figure United States Sorafenib Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Sorafenib Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Sorafenib Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Sorafenib Revenue Share by Players/Suppliers
Figure 2017 United States Sorafenib Revenue Share by Players/Suppliers
Table United States Market Sorafenib Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Sorafenib Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Sorafenib Market Share of Top 3 Players/Suppliers
Figure United States Sorafenib Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Sorafenib Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Sorafenib Product Category
Table United States Sorafenib Sales (K Pcs) by Region (2012-2017)
Table United States Sorafenib Sales Share by Region (2012-2017)
Figure United States Sorafenib Sales Share by Region (2012-2017)
Figure United States Sorafenib Sales Market Share by Region in 2016
Table United States Sorafenib Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Sorafenib Revenue Share by Region (2012-2017)
Figure United States Sorafenib Revenue Market Share by Region (2012-2017)
Figure United States Sorafenib Revenue Market Share by Region in 2016
Table United States Sorafenib Price (USD/Pcs) by Region (2012-2017)
Table United States Sorafenib Sales (K Pcs) by Type (2012-2017)
Table United States Sorafenib Sales Share by Type (2012-2017)
Figure United States Sorafenib Sales Share by Type (2012-2017)
Figure United States Sorafenib Sales Market Share by Type in 2016
Table United States Sorafenib Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Sorafenib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Sorafenib by Type (2012-2017)
Figure Revenue Market Share of Sorafenib by Type in 2016
Table United States Sorafenib Price (USD/Pcs) by Types (2012-2017)
Figure United States Sorafenib Sales Growth Rate by Type (2012-2017)
Table United States Sorafenib Sales (K Pcs) by Application (2012-2017)
Table United States Sorafenib Sales Market Share by Application (2012-2017)
Figure United States Sorafenib Sales Market Share by Application (2012-2017)
Figure United States Sorafenib Sales Market Share by Application in 2016
Table United States Sorafenib Sales Growth Rate by Application (2012-2017)
Figure United States Sorafenib Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Sorafenib Sales Growth Rate (2012-2017)
Figure Pfizer Sorafenib Sales Market Share in United States (2012-2017)
Figure Pfizer Sorafenib Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Sorafenib Sales Growth Rate (2012-2017)
Figure Allergan Sorafenib Sales Market Share in United States (2012-2017)
Figure Allergan Sorafenib Revenue Market Share in United States (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Sorafenib Sales Growth Rate (2012-2017)
Figure Alnylam Pharmaceuticals Sorafenib Sales Market Share in United States (2012-2017)
Figure Alnylam Pharmaceuticals Sorafenib Revenue Market Share in United States (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Acceleron Pharma Sorafenib Sales Growth Rate (2012-2017)
Figure Acceleron Pharma Sorafenib Sales Market Share in United States (2012-2017)
Figure Acceleron Pharma Sorafenib Revenue Market Share in United States (2012-2017)
Table Biocon Basic Information List
Table Biocon Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biocon Sorafenib Sales Growth Rate (2012-2017)
Figure Biocon Sorafenib Sales Market Share in United States (2012-2017)
Figure Biocon Sorafenib Revenue Market Share in United States (2012-2017)
Table Bionomics Basic Information List
Table Bionomics Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bionomics Sorafenib Sales Growth Rate (2012-2017)
Figure Bionomics Sorafenib Sales Market Share in United States (2012-2017)
Figure Bionomics Sorafenib Revenue Market Share in United States (2012-2017)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CASI Pharmaceuticals Sorafenib Sales Growth Rate (2012-2017)
Figure CASI Pharmaceuticals Sorafenib Sales Market Share in United States (2012-2017)
Figure CASI Pharmaceuticals Sorafenib Revenue Market Share in United States (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celgene Corporation Sorafenib Sales Growth Rate (2012-2017)
Figure Celgene Corporation Sorafenib Sales Market Share in United States (2012-2017)
Figure Celgene Corporation Sorafenib Revenue Market Share in United States (2012-2017)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Enzon Pharmaceuticals Sorafenib Sales Growth Rate (2012-2017)
Figure Enzon Pharmaceuticals Sorafenib Sales Market Share in United States (2012-2017)
Figure Enzon Pharmaceuticals Sorafenib Revenue Market Share in United States (2012-2017)
Table Five Prime Therapeutics Basic Information List
Table Five Prime Therapeutics Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Five Prime Therapeutics Sorafenib Sales Growth Rate (2012-2017)
Figure Five Prime Therapeutics Sorafenib Sales Market Share in United States (2012-2017)
Figure Five Prime Therapeutics Sorafenib Revenue Market Share in United States (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Genentech Basic Information List
Table Genexine Basic Information List
Table Hetero Drugs Basic Information List
Table ImClone Systems Basic Information List
Table Intas Pharmaceuticals Basic Information List
Table Levolta Pharmaceuticals Basic Information List
Table Mabtech Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sorafenib
Figure Manufacturing Process Analysis of Sorafenib
Figure Sorafenib Industrial Chain Analysis
Table Raw Materials Sources of Sorafenib Major Players/Suppliers in 2016
Table Major Buyers of Sorafenib
Table Distributors/Traders List
Figure United States Sorafenib Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Sorafenib Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Sorafenib Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Sorafenib Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Sorafenib Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Sorafenib Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Sorafenib Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Sorafenib Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Sorafenib Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Sorafenib Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Sorafenib Sales Volume Share Forecast by Region (2017-2022)
Figure United States Sorafenib Sales Volume Share Forecast by Region (2017-2022)
Figure United States Sorafenib Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources